Antibacterial nanofiber

Patent metadata

Field	Value
Publication number	US-10973775-B2
Application number	US-201816138577-A
Country	US
Kind code	B2
Filing date	Sep 21, 2018
Priority date	Sep 22, 2017
Publication date	Apr 13, 2021
Grant date	Apr 13, 2021

Abstract

Bacteria-responsive core-shell nanofibers and a process for the preparation thereof are described. The nanofibers release of an antibacterial agent in response to the presence of bacteria. The core of the nanofiber comprises a biocompatible polymer together with an antibacterial agent such as a quaternary ammonium compound, for example benzyl dimethyl tetradecyl ammonium chloride (BTAC). Surrounding the core is shell comprised of a bacterially degradable polymer, which is susceptible to break-down by bacterial enzymes such as lipase, or to acidic pH conditions. The shell may comprise, for example, polycaprolactone (PCL) and poly(ethylene succinate) (PES). The nanofibers may be incorporated into wound dressings.

First claim

What is claimed is:

1. A core-shell nanofiber comprising:
a core comprising an antibacterial agent and a biocompatible polymer;
a shell surrounding the core comprising a bacterially degradable polymer, said bacterially degradable polymer being responsive to bacterial colonization in a wound,
wherein the shell comprises polycaprolactone (PCL) and poly(ethylene succinate) (PES), said shell further comprising dyes that exhibit a color change when in contact with bacteria.

2. An electrospun nanofiber comprising at least one biocompatible polymer and dyes with colorimetric and fluorescent features that exhibit a color change in response to contact with bacteria.

3. The core-shell nanofiber of claim 1 , wherein the bacterially degradable polymer is degradable by bacterial enzyme activity or by a pH of 6 or less.

4. The core-shell nanofiber of claim 3 , wherein the enzyme is lipase.

5. The core-shell nanofiber of claim 1 , when prepared by the process comprising coaxially electrospinning a fiber to form a core material within a shell material.

6. A nanofiber mat comprising a plurality of core-shell nanofibers according to claim 1 .

7. An antibacterial wound dressing comprising the core-shell nanofiber of claim 1 .

8. A core-shell nanofiber comprising:
a core comprising benzyl dimethyl tetradecyl ammonium chloride (BTAC) and poly(vinylpyrrolidone) (PVP); and a diagnostic shell comprising polycaprolactone (PCL) and poly(ethylene succinate) (PES), and dyes with colorimetric and fluorescent features responsive to bacterial contact.

9. The core-shell nanofiber of claim 8 , wherein the core comprises BTAC in an amount from 2% to 5% by weight and PVP, and the shell comprises PCL and PES.

10. The nanofiber of claim 2 , further comprising an antibacterial agent comprising a quaternary ammonium compound (QAC).

11. A core-shell nanofiber comprising:
a core comprising a biocompatible polymer;
a shell surrounding the core comprising a bacterially degradable polymer and dyes with colorimetric and fluorescent features that exhibit a color change in response to bacterial colonization in a wound.

12. The core-shell nanofiber of claim 11 , wherein said color change is detectable with naked eyes.

13. The core-shell nanofiber of claim 11 , wherein said color change is detectable with a UV lamp.

14. The core-shell nanofiber of claim 11 , wherein the core further comprises an antibacterial agent.

Assignees

• Univ Manitoba

Inventors

• Liu Song
• Logsetty Sarvesh

Classifications

• D01D5/0007 Primary

  Electro-spinning (non-woven fabrics produced by electro-spinning D04H1/728) · CPC title

• D01F1/103

  Agents inhibiting growth of microorganisms · CPC title

• D01F8/10

  with at least one other macromolecular compound obtained by reactions only involving carbon-to-carbon unsaturated bonds as constituent · CPC title

• D01F8/14

  with at least one polyester as constituent · CPC title

• A61K9/0092

  Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes · CPC title